Products containing titanium dioxide in the EU are no longer required to carry warnings about cancer risk, after the European Chemicals Agency (Echa) revoked its classification as a suspected carcinogen. The move follows a June 2025 decision by the Court of Justice of the European Union and means that safety data sheets, labelling and packaging requirements for titanium dioxide have been relaxed across industries including paints, pharmaceuticals, cosmetics and food.
The decision is the latest in a decade-long regulatory debate. In 2016, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) proposed that powdered titanium dioxide should be classified as an ‘inhalation carcinogen’. Echa’s Committee for Risk Assessment (RAC) supported the proposal in 2017, leading to the European Commission listing the substance as a category 2 suspected carcinogen. This required products containing powdered titanium dioxide to carry the warning ‘H351: suspected of causing cancer when inhaled’.
Multiple manufacturers, downstream users and importers have mounted legal challenges to that ruling. In November 2022, the General Court of the European Union ruled that the commission had committed a ‘manifest error’ in using scientific evidence but failing to demonstrate intrinsic carcinogenicity of titanium dioxide. After more appeals from France and the European Commission were dismissed in August 2025, the classification was finally revoked. As a result, titanium dioxide products are no longer required to carry the warning label.
As industries and authorities adjust to this change, Echa and industry experts will continue to monitor advances in this area.
Reference:
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
Phosphorodiamidites are a unique class of phosphorus-based compounds characterized by one P–O bond and two P–N moieties. 2-Cyanoethyl tetraisopropylphosphorodiamidite plays a crucial role in solid-phase oligonucleotide synthesis. Beyond their application as synthetic precursors for oligonucleotides, phosphorodiamidites have also been reported as valuable starting materials for the synthesis of industrially relevant polymers and flame-resistant materials, including adhesives, coatings, and laminates.
Ferric maltol is an oral iron complex composed of ferric iron (Fe³⁺) chelated with maltol, designed to improve iron absorption while reducing common gastrointestinal side effects associated with traditional iron salts. It is primarily used in the management of iron deficiency with better tolerability.
Meet the ExSyn team at Biologics Festival India 2025
February 10 – 11, 2026
Hyatt Regency, Pune, India